AVE 33.3% 0.2¢ avecho biotechnology limited

buy side building strongly, page-92

  1. 5,322 Posts.
    JF I find your views annoying and simplistic . Have you ever run a large multi million dollar enterprise? POHs Management must strive to meet KPIs while conserving and maximising cash . You suggest we waste precious cash reserves in a manner that is neither prudent or required at this point in our rollout. Your rather tedious and endless posts on marketing fail to recognize that all Elixia's new distribution agreements will have a % of sales dedicated to "co-op" marketing which is highly effective and targeted to the sell thru of stock at store level. Your derision of POHs business strategies and management is completely at odds with what most knowledgeable industry observers believe ..... And .....look a little silly in light of POHs amazing achievements in commercializing it's blockbuster platform technology. You claim to have expertise in marketing....why not put forward some real ideas so we can judge you rather than constantly swinging the wrecking ball !!
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(33.3%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $17 5.798K

Buyers (Bids)

No. Vol. Price($)
55 95690716 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 59980558 19
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.